Cargando…
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248552/ https://www.ncbi.nlm.nih.gov/pubmed/32574259 http://dx.doi.org/10.3389/fimmu.2020.01021 |
| _version_ | 1783538399175507968 |
|---|---|
| author | Shah, Adnan |
| author_facet | Shah, Adnan |
| author_sort | Shah, Adnan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7248552 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72485522020-06-05 Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 Shah, Adnan Front Immunol Immunology Frontiers Media S.A. 2020-05-19 /pmc/articles/PMC7248552/ /pubmed/32574259 http://dx.doi.org/10.3389/fimmu.2020.01021 Text en Copyright © 2020 Shah. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Shah, Adnan Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title | Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title_full | Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title_fullStr | Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title_full_unstemmed | Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title_short | Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 |
| title_sort | novel coronavirus-induced nlrp3 inflammasome activation: a potential drug target in the treatment of covid-19 |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248552/ https://www.ncbi.nlm.nih.gov/pubmed/32574259 http://dx.doi.org/10.3389/fimmu.2020.01021 |
| work_keys_str_mv | AT shahadnan novelcoronavirusinducednlrp3inflammasomeactivationapotentialdrugtargetinthetreatmentofcovid19 |